Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment

Annals of the New York Academy of Sciences

Volumn 996, Issue , 2003, Pages 49-60

  Rafii, Shahin ^a   Avecilla, Scott ^a   Shmelkov, Sergey ^a   Shido, Koji ^a   Tejada, Rafael ^a   Moore, Malcolm A S ^a   Heissig, Beate ^a   Hattori, Koichi ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Angiogenesis; Angiopoietin; Bone marrow; Chemokines; Hematopoiesis; Mobilization; Shear stress; Stem cells; Tyrosine kinase receptors; Vascular endothelial growth factor; Vascularization; Vasculogenesis

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; CD34 ANTIGEN; CHEMOKINE; GELATINASE B; GROWTH FACTOR; PLACENTAL GROWTH FACTOR; STEM CELL FACTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; BONE MARROW; BONE MARROW SUPPRESSION; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOTAXIS; CONFERENCE PAPER; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SHEAR STRESS; SIGNAL TRANSDUCTION; STEM CELL; UPREGULATION;

ANIMALIA;

EID: 0038806646     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03232.x     Document Type: Conference Paper

References (65)

1. CHENG, T., N. RODRIGUES, H. SHEN, et al. 2000. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287: 1804-1808.
2. PHILLIPS, R.L., R.E. ERNST, B. BRUNK, et al. 2000. The genetic program of hematopoietic stem cells. Science 288: 1635-1640.
3. KRAUSE, D.S., N.D. THEISE, M.I. COLLECTOR, et al. 2001. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105: 369-377.
4. HATTORI, K., S. DIAS, B. HEISSIG, et al. 2001. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med. 193: 1005-1014.
5. TAKAHASHI T, C. KALKA, H. MASUDA, et al. 1999. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5: 434-438.
6. GILL, M., S. DIAS, K. HATTORI, et al. 2001. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ. Res. 88: 167-174.
7. PELED, A., I. PETIT, O. KOLLET, et al. 1999. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283: 845-851.
8. LEMISCHKA, I.R., D.H. RAULET & R.C. MULLIGAN. 1986. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 45: 917-927.
9. ASAHARA, T., T. MUROHARA, A. SULLIVAN, et al. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
10. ASAHARA, T., H. MASUDA, T. TAKAHASHI, et al. 1999. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85: 221-228.
11. ASAHARA, T., T. TAKAHASHI, H. MASUDA, et al. 1999. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. Embo. J. 18: 3964-3972.
12. CRISA, L., V. CIRULLI, K.A. SMITH, et al. 1999. Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis. Blood 94: 3928-39240.
13. ORLIC, D., J. KAJSTURA, S. CHIMENTI, et al. 2000. Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705.
14. ORLIC, D., J. KAJSTURA, S. CHIMENTI, et al. 2001. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA 98: 10344-10349.
15. ORLIC, D., J. KAJSTURA, S. CHIMENTI, et al. 2001. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann. N.Y. Acad. Sci. 938: 221-229; discussion 229-230.
16. KOCHER, A.A., M.D. SCHUSTER, M.J. SZABOLCS, et al. 2001. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7: 430-436.
17. IWAGURO, H., J. YAMAGUCHI, C. KALKA, et al. 2002. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105: 732-738.
18. KALKA, C., H. MASUDA, T. TAKAHASHI, et al. 2000. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA 97: 3422-3427.
19. SCHATTEMAN, G.C., H.D. HANLON, C. JIAO, et al. 2000. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J. Clin. Invest. 106: 571-578.
20. SHI, Q., S. RAFII, M.H. WU, et al. 1998. Evidence for circulating bone marrow-derived endothelial cells. Blood 92: 362-367.
21. BHATTACHARYA, V., P.A. MCSWEENEY, Q. SHI, et al. 1999. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood 95: 581-585.
22. SATA, M., A. SAIURA, A. KUNISATO, et al. 2002. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8: 403-409.
23. OTANI, A., K. KINDER, K. EWALT, et al. 2002. Bone marrow derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat. Med. 29: 29.
24. GRANT, M.B., W.S. MAY, S. CABALLERO, et al. 2002. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 8: 607-612.
25. LYDEN, D., K. HATTORI, S. DIAS, et al. 2001. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7: 1194-1201.
26. REYES, M., A. DUDEK, B. JAHAGIRDAR, et al. 2002. Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest. 109: 337-346.
27. MOORE, M.A. 2002. Putting the neo into neoangiogenesis. J. Clin. Invest. 109: 313-315.
28. GEHLING, U.M., S. ERGUN, U. SCHUMACHER, et al. 2000. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95: 3106-3112.
29. MARCHETTI, S., C. GIMOND, K. ILJIN, et al. 2002. Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo. J. Cell Sci. 115: 2075-2085.
30. DAVIDOFF, A.M., C.Y. NG, P. BROWN, et al. 2001. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin. Cancer Res. 7: 2870-2879.
31. BERARDI, A.C., A. WANG, J.D. LEVINE, et al. 1995. Functional isolation and characterization of human hematopoietic stem cells. Science 267: 104-108.
32. CARMELIET, P. & R.K. JAIN. 2000. Angiogenesis in cancer and other diseases. Nature 407: 249-257.
33. HANAHAN, D. & J. FOLKMAN. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
34. CARMELIET, P., L. MOONS, A. LUTTUN, et al. 2001. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7: 575-583.
35. KABRUN, N., H.J. BUHRING, K. CHOI, et al. 1997. Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 124: 2039-2048.
36. SHALABY, F., J. ROSSANT, T.P. YAMAGUCHI, et al. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66.
37. SHALABY, F., J. HO, W.L. STANFORD, et al. 1997. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89: 981-990.
38. FONG, G.H., J. ROSSANT, M. GERTSENSTEIN & M.L. BREITMAN. 1995. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70.
39. FONG, G.H., L. ZHANG, D.M. BRYCE & J. PENG. 1999. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development 126: 3015-3025.
40. HIRATSUKA, S., O. MINOWA, O. KUNO, et al. 1998. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA 95: 9349-9354.
41. HIRATSUKA, S., Y. MARU, A. OKADA, et al. 2001. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. Cancer Res. 61: 1207-1213.
42. HIRATSUKA, S. 2002. The tyrosine kinase domain of Flt-1 (vascular endothelial growth factor receptor-1) is required for a tumor angiogenesis and its progression. Proc. Am. Assoc. Cancer Res. [vol. #?] 43.
43. ZIEGLER, B.L., M. VALTIERI, G.A. PORADA, et al. 1999. KDR receptor: a key marker defining hematopoietic stem cells. Science 285: 1553-1558.
44. HARUTA, H., Y. NAGATA & K. TODOKORO. 2001. Role of Flk-1 in mouse hematopoietic stem cells. FEBS Lett. 507: 45-48.
45. SAWANO, A., S. IWAI, Y. SAKURAI, et al. 2001. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97: 785-791.
46. CLAUSS, M., H. WEICH, G. BREIER, et al. 1996. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271: 17629-17634.
47. BARLEON, B., S. SOZZANI, D. ZHOU, et al. 1996. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87: 3336-3343.
48. CHO, N.K., L. KEYES, E. JOHNSON, et al. 2002. Developmental control of blood cell migration by the Drosophila VEGF pathway. Cell 108: 865-876.
49. HATTORI, K., B. HEISSIG, Y. WU, et al. 2002. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat. Med. 8: 841-849.
50. HEISSIG, B., K. HATTORI, S. DIAS, et al. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires mmp-9 mediated release of kit-ligand. Cell 109: 625-637.
51. MORRISON, S.J., A.M. WANDYCZ, H.D. HEMMATI, et al. 1997. Identification of a lineage of multipotent hematopoietic progenitors. Development 124: 1929-1939.
52. MORRISON, S.J., D.E. WRIGHT & I..L. WEISSMAN. 1997. Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc. Natl. Acad. Sci. USA 94: 1908-1913.
53. HUANG XL, TAKAKURA N & SUDA T. 1999. In vitro effects of angiopoietins and VEGF on hematopoietic and endothelial cells. Biochem. Biophys. Res. Commun. 264: 133-138.
54. BROXMEYER, H.E., S. COOPER, Z.H. LI, et al. 1995. Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor. Int. J. Hematol. 62: 203-215.
55. RATAJCZAK, M.Z., J. RATAJCZAK, B. MACHALINSKI, et al. 1998. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth. Br. J. Haematol. 103: 969-979.
56. GERBER, H.P., A.K. MALIK, G.P. SOLAR, et al. 2002. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417: 954-958.
57. VU, T.H. & Z. WERB. 2000. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 14: 2123-2133.
58. ENGSIG, M.T., Q.J. CHEN, T.H. VU, et al. 2000. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell. Biol. 151: 879-890.
59. BERGERS, G., R. BREKKEN, G. MCMAHON, et al. 2000. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell. Biol. 2: 737-744.
60. HUANG, E.J., K.H. NOCKA, J. BUCK & P. BESMER. 1992. Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol. Biol. Cell 3: 349-362.
61. LONGLEY, B.J., L. TYRRELL, Y. MA, et al. 1997. Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc. Natl. Acad. Sci. USA 94: 9017-9021.
62. KRIDEL, S.J., E. CHEN, L.P. KOTRA, et al. 2001. Substrate hydrolysis by matrix metalloproteinase-9. J. Biol. Chem. 276: 20572-20578.
63. PRUIJT, J.F., W.E. FIBBE, L. LATERVEER, et al. 1999. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc. Natl. Acad. Sci. USA 96: 10863-10868.
64. MASURE S, PAEMEN L, VAN AELST I, et al. 1997. Production and characterization of recombinant active mouse gelatinase B from eukaryotic cells and in vivo effects after intravenous administration. Eur. J. Biochem. 244: 21-30.
65. HATTORI, K., B. HEISSIG, K. TASHIRO, et al. 2000. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97: 3354-3360.